These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 25155209)
1. The burden of rare cancer in Japan: application of the RARECARE definition. Tamaki T; Dong Y; Ohno Y; Sobue T; Nishimoto H; Shibata A Cancer Epidemiol; 2014 Oct; 38(5):490-5. PubMed ID: 25155209 [TBL] [Abstract][Full Text] [Related]
2. Rare cancers in The Netherlands: a population-based study. van der Zwan JM; van Dijk BAC; Visser O; van Krieken HJHJM; Capocaccia R; Siesling S Eur J Cancer Prev; 2018 Jul; 27(4):384-390. PubMed ID: 25969132 [TBL] [Abstract][Full Text] [Related]
3. Burden and centralised treatment in Europe of rare tumours: results of RARECAREnet-a population-based study. Gatta G; Capocaccia R; Botta L; Mallone S; De Angelis R; Ardanaz E; Comber H; Dimitrova N; Leinonen MK; Siesling S; van der Zwan JM; Van Eycken L; Visser O; Žakelj MP; Anderson LA; Bella F; Kaire I; Otter R; Stiller CA; Trama A; Lancet Oncol; 2017 Aug; 18(8):1022-1039. PubMed ID: 28687376 [TBL] [Abstract][Full Text] [Related]
4. Rare cancers are not rare in Asia as well: The rare cancer burden in East Asia. Matsuda T; Won YJ; Chun-Ju Chiang R; Lim J; Saika K; Fukui K; Lee WC; Botta L; Bernasconi A; Trama A Cancer Epidemiol; 2020 Aug; 67():101702. PubMed ID: 32535408 [TBL] [Abstract][Full Text] [Related]
5. Rare cancers are not so rare: the rare cancer burden in Europe. Gatta G; van der Zwan JM; Casali PG; Siesling S; Dei Tos AP; Kunkler I; Otter R; Licitra L; Mallone S; Tavilla A; Trama A; Capocaccia R; Eur J Cancer; 2011 Nov; 47(17):2493-511. PubMed ID: 22033323 [TBL] [Abstract][Full Text] [Related]
6. Rationale of the rare cancer list: a consensus paper from the Joint Action on Rare Cancers (JARC) of the European Union (EU). Casali PG; Trama A ESMO Open; 2020 Mar; 5(2):. PubMed ID: 32220947 [TBL] [Abstract][Full Text] [Related]
7. The burden of rare cancers in Europe. Gatta G; Capocaccia R; Trama A; Martínez-García C; Adv Exp Med Biol; 2010; 686():285-303. PubMed ID: 20824452 [TBL] [Abstract][Full Text] [Related]
8. Methodological aspects of estimating rare cancer prevalence in Europe: the experience of the RARECARE project. Mallone S; De Angelis R; van der Zwan JM; Trama A; Siesling S; Gatta G; Capocaccia R; Cancer Epidemiol; 2013 Dec; 37(6):850-6. PubMed ID: 24050903 [TBL] [Abstract][Full Text] [Related]
9. Data quality in rare cancers registration: the report of the RARECARE data quality study. Trama A; Marcos-Gragera R; Sánchez Pérez MJ; van der Zwan JM; Ardanaz E; Bouchardy C; Melchor JM; Martinez C; Capocaccia R; Vicentini M; Siesling S; Gatta G; Tumori; 2017 Jan; 103(1):22-32. PubMed ID: 27716878 [TBL] [Abstract][Full Text] [Related]
10. Incidence of rare cancers in the city of São Paulo, Brazil. Bustamante-Teixeira MT; Latorre MDRDO; Guerra MR; Tanaka LF; Botta L; Trama A; Gatta G Tumori; 2019 Feb; 105(1):22-30. PubMed ID: 30700226 [TBL] [Abstract][Full Text] [Related]
11. Rare cancers in Japan: definition, clinical features and future perspectives. Kawai A; Higashi T; Shibata T; Yoshida A; Katoh Y; Fujiwara Y; Nishida T Jpn J Clin Oncol; 2020 Sep; 50(9):970-975. PubMed ID: 32719865 [TBL] [Abstract][Full Text] [Related]
12. The burden of rare cancers in Italy: the surveillance of rare cancers in Italy (RITA) project. Trama A; Mallone S; Ferretti S; Meduri F; Capocaccia R; Gatta G; Tumori; 2012; 98(5):550-8. PubMed ID: 23235748 [TBL] [Abstract][Full Text] [Related]
13. Defining and listing very rare cancers of paediatric age: consensus of the Joint Action on Rare Cancers in cooperation with the European Cooperative Study Group for Pediatric Rare Tumors. Ferrari A; Brecht IB; Gatta G; Schneider DT; Orbach D; Cecchetto G; Godzinski J; Reguerre Y; Bien E; Stachowicz-Stencel T; Ost M; Magni C; Kearns P; Vassal G; Massimino M; Biondi A; Bisogno G; Trama A Eur J Cancer; 2019 Mar; 110():120-126. PubMed ID: 30785015 [TBL] [Abstract][Full Text] [Related]
14. Time trend analysis of rare cancer incidence 2011-2018: Nationwide population-based cancer registries in Japan. Sugiyama H; Konda M; Saika K; Matsuda T Cancer Sci; 2024 Jul; 115(7):2417-2443. PubMed ID: 38613332 [TBL] [Abstract][Full Text] [Related]
15. Rare cancers of the head and neck area in Europe. Van Dijk BA; Gatta G; Capocaccia R; Pierannunzio D; Strojan P; Licitra L; Eur J Cancer; 2012 Apr; 48(6):783-96. PubMed ID: 22051735 [TBL] [Abstract][Full Text] [Related]
16. Descriptive epidemiological study of rare, less common and common cancers in Western Australia. Bilkey GA; Trevithick RW; Coles EP; Girschik J; Nowak KJ BMC Cancer; 2021 Jul; 21(1):779. PubMed ID: 34233636 [TBL] [Abstract][Full Text] [Related]
17. Cancer incidence and incidence rates in Japan in 2005: based on data from 12 population-based cancer registries in the Monitoring of Cancer Incidence in Japan (MCIJ) project. Matsuda T; Marugame T; Kamo K; Katanoda K; Ajiki W; Sobue T; Jpn J Clin Oncol; 2011 Jan; 41(1):139-47. PubMed ID: 20819836 [TBL] [Abstract][Full Text] [Related]
18. Survival of cancer patients diagnosed between 1993 and 1996: a collaborative study of population-based cancer registries in Japan. Tsukuma H; Ajiki W; Ioka A; Oshima A; Jpn J Clin Oncol; 2006 Sep; 36(9):602-7. PubMed ID: 16870692 [TBL] [Abstract][Full Text] [Related]
19. [Cancer incidence in Japan]. Tsukuma H; Ajiki W; Oshima A Gan To Kagaku Ryoho; 2004 Jun; 31(6):840-6. PubMed ID: 15222098 [TBL] [Abstract][Full Text] [Related]
20. Cancer incidence and incidence rates in Japan in 2004: based on data from 14 population-based cancer registries in the Monitoring of Cancer Incidence in Japan (MCIJ) Project. Matsuda T; Marugame T; Kamo K; Katanoda K; Ajiki W; Sobue T; Jpn J Clin Oncol; 2010 Dec; 40(12):1192-200. PubMed ID: 20647231 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]